Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT07177404
Brief Summary:
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs.
The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
Detailed Description:
This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop.
The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy.
The secondary objectives of the study are:
* To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes
* To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy
Study:
NCT07177404
Study Brief:
Protocol Section:
NCT07177404